Replies to post #2351 on Skye Bioscience Inc (SKYE)

[AntonChigurh]

There is a somewhat detailed presentation on it in the PP I linked to.

Also, why not given them 5-10% of the global market when discounting their cash flows? MRSA seems completed, all these different strains, won't there be more than one medication used for the next while? Nothing seems to be a cure all...